-
Markets
athexgroup.grAthens Exchange GroupRead moreTogether for a unified, stronger European capital market.
-
Equities
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Commodities
- Overview
- Agricultural quotes
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Container Freight Futures
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Aqua Bio Technology ASA: Key information relating to the Subsequent Offering
12 Feb 2026 23:56 CET
Reference is made to the announcement by Aqua Bio Technology ASA on 12
February 2026 concerning the successful placement of the conditional private
placement (the "Private Placement") with total gross proceeds of NOK 10
million, and a contemplated subsequent offering (the "Subsequent Offering").
Key information for the Subsequent Offering is set out below:
Date on which the terms of the Subsequent Offering was announced: 12 February
2026
Last day including right: 12 February 2026
First day excluding right: 13 February 2026
Record date: 16 February 2026
Maximum number of new shares: 800,000
Subscription price: NOK 5.00
Shall the rights be listed: No
The issuance of new shares in the Subsequent Offering (the "Offer Shares")
will be subject to grant of a board authorization to increase the share
capital, as well as completion of the Private Placement, and the Company
reserves the right in its sole discretion to not conduct or cancel the
Subsequent Offering.
This information is published in accordance with the requirements of the
Continuing Obligations in Euronext Rule Book II.
Contacts
Kristian Flaten
CEO & CFO
Aqua Bio Technology ASA
Phone: +47 9509 2322
Email: kf@aquabiotech.no
About Us
Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in
skincare and nonfood. The group has distribution towards B2C and B2B, and
offers freight, customs, and logistics services. The group also develops
sustainable biotechnology for use in skincare products. Aqua Bio Technology is
listed on Euronext Expand Oslo.
This notice is published by Kristian Flaten on the listed date and time.
This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR Article 17. The information was submitted for publication,
through the agency of the contact persons set out above, at 2026-02-12 23:56
CET.
More information:
Access the news on Oslo Bors NewsWeb site
665738_Aqua Bio Technology ASA- Key information relating to the Subsequent Offering.pdf
Source
Aqua Bio Technology ASA
Provider
Oslo Børs Newspoint
Company Name
AQUA BIO TECHNOLOGY
ISIN
NO0010307135, NO0013735894
Symbol
ABTEC
Market
Euronext Expand